2m 2m 2m 2m 2m 2m 2m
FB 9.375%CCRPP-A (FBIOP)
NASDAQ
$20.79+$0.36 (+1.74%)
Price as of Jun 03, 2026 4:00 PM EDT- $66.7MMarket Cap
- 154.42%1-Year Change
- BiotechnologyIndustry
FB 9.375%CCRPP-A (FBIOP)
$20.79+$0.36 (+1.74%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 63.3M +9.69% | 57.7M -31.76% | 84.5M +11.58% | 75.7M +10.11% | |
Cost of Revenue | 20.9M +0.22% | 20.9M -21.68% | 26.7M -13.37% | 30.8M -4.08% | |
Gross Profit | 42.3M +15.06% | 36.8M -36.40% | 57.9M +28.65% | 45.0M +22.51% | |
Sales and Marketing Expense | 96.4M +9.88% | 87.7M -6.79% | 94.1M -17.19% | 113.7M +30.88% | |
Research and Development Expense | -11.9M -78.98% | -56.6M -44.34% | -101.7M -24.18% | -134.2M +18.51% | |
Depreciation and Amortization Expense | 4.3M +24.36% | 3.4M -9.11% | 3.8M +21.16% | 3.1M +18.30% | |
Total Operating Expenses | 133.5M -20.57% | 168.1M -25.92% | 226.9M -18.78% | 279.3M +8.54% | |
Operating Profit | -70.2M -36.38% | -110.4M -22.46% | -142.3M -30.08% | -203.6M +7.97% | |
Interest Income | 2.5M -7.38% | 2.7M -10.66% | 3.0M +114.81% | 1.4M +115.41% | |
Interest Expense | -100,000 -96.43% | -2.8M 0.00% | -2.8M +25,354.55% | -11,000 N/A | |
Interest Income and Expense and Net | 2.4M +2,138.46% | -117,000 -157.64% | 203,000 -85.36% | 1.4M +113.71% | |
Total Nonoperating Income and Expense | 36.7M +460.94% | -10.2M -9.98% | -11.3M +14.05% | -9.9M -140.93% | |
Income before Taxes | -33.5M -72.18% | -120.5M -21.54% | -153.6M -28.03% | -213.5M +29.88% | |
Income Taxes | -620,000 -298.72% | 312,000 -37.60% | 500,000 +11.36% | 449,000 -5.07% | |
Extraordinary Items | 0 -100.00% | 3.7M +19.10% | 3.1M N/A | N/A N/A | |
Net Income | 6.8M +114.82% | -46.0M -24.14% | -60.6M -29.96% | -86.6M +33.80% | |
Net Income from Continuing Operations Applicable to Common | -1.9M -96.63% | -55.9M -18.61% | -68.7M -67.83% | -213.5M +29.88% | |
Basic EPS and Net Income | -0.07 -97.40% | -2.69 -68.24% | -8.47 +773.20% | -0.97 +22.78% | |
Diluted EPS and Net Income | -0.07 -97.40% | -2.69 -68.24% | -8.47 +773.20% | -0.97 +22.78% | |
Basic Weighted Average Shares | 27.9M +34.24% | 20.8M +156.25% | 8.1M -90.87% | 88.9M +8.78% | |
Diluted Weighted Average Shares | 27.9M +34.24% | 20.8M +156.25% | 8.1M -90.87% | 88.9M +8.78% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 79.4M +38.63% | 57.3M -29.24% | 80.9M -54.60% | 178.3M -41.69% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 79.4M +38.63% | 57.3M -29.24% | 80.9M -54.60% | 178.3M -41.69% | |
Total Current Assets | 123.8M +37.04% | 90.4M -22.77% | 117.0M -49.22% | 230.4M -33.49% | |
Accumulated Depreciation | 3.0M -70.12% | 9.9M +11.70% | 8.9M -28.56% | 12.4M +32.49% | |
Property and Plant and Equipment and Net | 2.5M -22.73% | 3.3M -49.88% | 6.5M -50.04% | 13.0M -13.58% | |
Total Long-Term Assets | 401,000 -87.91% | 3.3M -22.60% | 4.3M +340.29% | 973,000 -18.78% | |
Total Assets | 185.5M +28.65% | 144.2M -13.91% | 167.5M -43.08% | 294.3M -25.78% | |
Income Taxes Payable | 356,000 -61.80% | 932,000 +10.56% | 843,000 +16.76% | 722,000 +109.28% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 2.9M +263.05% | |
Total Current Liabilities | 49.7M -30.33% | 71.4M -15.91% | 84.9M -33.52% | 127.7M +26.40% | |
Total Long-Term Debt | 52.4M -9.57% | 58.0M -4.76% | 60.9M -33.66% | 91.7M +113.64% | |
Total Long-Term Liabilities | 1.4M -17.60% | 1.8M -7.24% | 1.9M +2.49% | 1.8M -9.15% | |
Total Liabilities | 123.4M -15.43% | 145.9M -12.10% | 165.9M -32.07% | 244.3M +43.16% | |
Retained Earnings | -734.1M -0.92% | -740.9M +6.62% | -694.9M +9.56% | -634.2M +15.85% | |
Total Stockholders Equity | 49.9M +119.35% | 22.7M +0.86% | 22.5M -45.96% | 41.7M -61.61% | |
Total Shares Outstanding | 31.4M +12.38% | 27.9M +84.91% | 15.1M -86.34% | 110.5M +8.93% | |
Cash Flow | |||||
Cash from Operating Activities | -65.8M -17.97% | -80.2M -37.46% | -128.2M -28.53% | -179.4M +53.94% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 63,000 -97.68% | 2.7M -40.54% | |
Cash from Investing Activities | 10.1M +167.47% | -15.0M +613.27% | -2.1M -90.83% | -22.9M -156.59% | |
Dividends Paid | 664,000 -4.32% | 694,000 -5.71% | 736,000 -1.74% | 749,000 0.00% | |
Cash from Financing Activities | 77.4M +9.63% | 70.6M +115.77% | 32.7M -56.53% | 75.3M -49.45% | |
Financials Ratio | |||||
Gross Margin | 66.92% +4.90% | 63.80% -6.80% | 68.45% +15.30% | 59.37% +11.26% | |
Operating Margin | -111.00% -42.00% | -191.38% +13.63% | -168.43% -37.33% | -268.76% -1.94% | |
Return on Assets | 4.13% +114.01% | -29.51% +12.37% | -26.26% +4.77% | -25.06% +40.49% | |
Return on Equity | 18.77% +109.24% | -203.16% +7.66% | -188.71% +63.91% | -115.13% +85.95% | |
Revenue Growth | 9.69% +130.50% | -31.76% -374.27% | 11.58% +14.57% | 10.11% -80.13% | |
Current Ratio | 2.49 +96.70% | 1.27 -8.16% | 1.38 -23.62% | 1.80 -47.38% | |
Cash Ratio | 1.60 +98.98% | 0.80 -15.85% | 0.95 -31.72% | 1.40 -53.87% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 2.70 +18.95% | 2.27 +463.66% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.36 +12.93% | 0.32 +191.66% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow